November 17th 2024
At the SDPA Fall Conference, Miranti emphasized the importance of targeted, comprehensive acne therapies and inspired attendees to embrace pediatric dermatology as a rewarding subspecialty.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Dermatologists see similar medical conditions
July 1st 2001There is no doubt cosmetic dermatology has grown as a proportion of dermatology practices, but it has not taken over the specialty completely. On Call talked to a number of dermatologists around the country who consider themselves general dermatologists. They work as solo practitioners, in groups and in large hospital settings. They have been in practice for 20 years or four years.
Patient Concerns: Self-diagnosis
June 1st 2001Q. I'm African-American and I have beige spots all over my body (except my face). My doctor said they are vitiligo, but I disagree. According to a book I have, they resemble something called epidermodysplasia verruciformis, which can lead to carcinoma. Is there a natural cure for these ailments?
Permanent hair dyes cause contact urticaria, anaphylaxis
June 1st 2001Palm Beach, Fla. - Paraphenylenediamine, or PPD, the main chemical used in permanent hair dye colors, is the third most common cosmetic allergen, preceded by preservatives (No. 1) and fragrances (No. 2), James S. Taylor, M.D., said at annual meeting of the Noah Worcester Dermatological Society.
Better awareness of airborne irritant problems is necessary
June 1st 2001Hershey, Pa. - There is potential for growing problems from the use of triglycidyl isocyanurate, which is used as a hardener in thermosetting polyester powder coatings in products ranging from patio furniture to auto parts, said Bruce A. Brod, M.D., in an address at the American Contact Dermatitis Society gathering that highlighted state-of-the-art issues.
HAART advent shown to improve most dermatologic conditions
June 1st 2001Vancouver, British Columbia - In his 20 years of working with HIV/AIDS patients, Alastair McLeod, M.D., has seen a dramatic change in the incidence and severity of several skin conditions common to the disease. The advent of highly active antiretroviral therapy has eliminated some conditions and greatly improved others, yet other conditions have not shown marked improvement with the drugs.
Hot topics in contact dermatitis
June 1st 2001Washington - Two topics - metal allergies and their effect on restenosis in stents, and the debate as to whether flu shots should be denied to those with thimerosal allergies - top a list of contact dermatitis concerns, according to an expert on the condition.
Antiviral vaccine rebounds versus herpes
June 1st 2001Washington - A glycoprotein vaccine has induced significant protection against genital herpes disease in women with no evidence of either herpes simplex virus 1 or HSV 2 infection, said Stephen K. Tyring, M.D., Ph.D., at the annual meeting of the American Academy of Dermatology.